CRISPR Therapeutics AG (CRSP) quarterly cash flow statement — complete operating, investing & financing history
CRISPR Therapeutics AG (CRSP) cash flow statement — 12-year operating, investing & financing cash flows
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Cash from Operations | -89.68M | -83.5M | -108.9M | -92.55M | -84.63M | -113.88M | -53.95M | -50.03M | -106.91M | -95.58M | 109.75M | -96.07M | -39.86M | -133.25M | 8.8M | -113.33M | -105.22M | -141.96M | -135.24M | -86.04M |
| Operating CF Margin % | -707.9% | -820.14% | -7468.93% | -10712.15% | -9520.14% | -12766.82% | -6236.65% | -142.95% | -17759.63% | -18487.81% | 21776.19% | -48.04% | - | -190.35% | 8.8% | -1888800% | -111934.04% | -89845.57% | -75976.97% | -667.01% |
| Operating CF Growth % | -5.97% | 26.68% | -101.86% | -84.99% | 20.84% | -19.14% | -149.15% | 47.92% | -168.25% | 28.27% | 1147.32% | 15.23% | 62.12% | 6.14% | 106.51% | -31.72% | -29.37% | -117.59% | -34.35% | -5.94% |
| Net Income | -111.44M | -91.15M | -122.93M | -130.61M | -106.44M | -208.55M | -136M | -37.31M | -85.94M | -126.41M | -116.59M | 89.35M | -112.15M | -77.74M | -53.06M | -110.58M | -174.55M | -185.83M | -179.22M | -141.25M |
| Depreciation & Amortization | 4.24M | 4.28M | 4.32M | 5.66M | 4.43M | 4.65M | 4.74M | 4.84M | 4.74M | 4.84M | 4.83M | 4.9M | 4.92M | 4.96M | 5.05M | 5.85M | 5.02M | 7.27M | 6.04M | 6.26M |
| Stock-Based Compensation | 17.96M | 17.32M | 16.32M | 18.08M | 16.6M | 17.61M | 20.21M | 21.95M | 21.54M | 23.67M | 19.41M | 18.42M | 19.97M | 21.77M | 20.88M | 22.8M | 24.55M | 24.85M | 25.75M | 25.77M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -2.6M | -10.24M | 8.8M | -8.31M | -10.14M | 88.92M | 2.25M | -15.15M | -6.9M | -8.18M | -8.38M | -4.77M | -5.16M | -3.15M | -969K | 219K | 2.58M | 3.57M | 6.1M | 4.69M |
| Working Capital Changes | 2.15M | -3.7M | -15.41M | 22.64M | 10.91M | -16.51M | 54.85M | -24.35M | -40.36M | 10.49M | 210.49M | -203.97M | 52.56M | -79.08M | 36.91M | -31.62M | 37.19M | 8.19M | 6.09M | 18.49M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 25M | -25M | 0 | 0 | 200M | -200M | 70M | -70M | 0 | 49K | 17K | 77K | 162K | -153K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27.96M | 0 | 0 | 0 |
| Change in Payables | 20.61M | 0 | 0 | 0 | 12.18M | -14.7M | 0 | 0 | 0 | 0 | 0 | -9.19M | -24.69M | -11.58M | 25.21M | -31.1M | 27.96M | 0 | -1.62M | 22.78M |
| Cash from Investing | -14.09M | -55.66M | -410.74M | 37.2M | -119.23M | 69.98M | -19.75M | 105.83M | -161.6M | -126.91M | -97.8M | -81.45M | 121.35M | 216.92M | 117.83M | -175.53M | 87.46M | -56.07M | -114.52M | -8.72M |
| Capital Expenditures | -414K | -648K | -504K | -517K | -74K | -117K | -206K | -254K | -219K | -707K | -721K | -738K | -2.12M | -3.56M | -3.06M | -6.19M | -6.02M | -9.63M | -15.35M | -9.18M |
| CapEx % of Revenue | 3.27% | 6.36% | 34.57% | 59.84% | 8.32% | 13.12% | 23.82% | 0.73% | 36.38% | 136.75% | 143.06% | 0.37% | - | 5.08% | 3.06% | 103183.33% | 6401.06% | 6094.94% | 8623.6% | 71.19% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -93.48M | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 825K | -2.47M | 0 | 0 | 0 | -25M | 0 | 0 | 0 | 0 | 0 | 0 | -1M | -1.5M | 0 | 0 | 93.48M | 0 | 0 | 0 |
| Cash from Financing | 4.45M | 7.18M | 591.91M | 116.41M | 296.77M | 2.26M | 10.59M | 16.88M | 9.64M | -466K | 305.93M | 38.94M | 1.56M | 16.77M | 5.4M | 2.48M | 15.11M | 10.35M | 10.65M | 6.3M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.45M | 8.3M | 591.91M | 116.41M | 278.11M | 2.26M | 8.52M | 14.96M | 6M | -1.01M | 280.75M | 38.94M | 1.56M | 16.77M | 5.4M | 2.48M | 970K | 0 | 10.65M | 6.3M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1.12M | 0 | 0 | 18.66M | 0 | 2.07M | 1.92M | 3.64M | 546K | 25.19M | 0 | 0 | 0 | 0 | 0 | 14.14M | 10.35M | 0 | 0 |
| Net Change in Cash | -99.31M | -131.97M | 68.52M | 61.06M | 92.88M | -41.56M | -63.07M | 72.59M | -258.8M | -222.95M | 317.88M | -138.29M | 82.97M | 100.39M | 132.52M | -282.27M | -2.74M | -187.74M | -239.13M | -88.52M |
| Free Cash Flow | -90.1M | -86.62M | -109.4M | -93.07M | -84.71M | -114M | -54.15M | -50.28M | -107.13M | -96.29M | 109.03M | -96.81M | -41.97M | -136.8M | 5.74M | -119.52M | -111.23M | -151.59M | -150.59M | -95.22M |
| FCF Margin % | -711.17% | -850.79% | -7503.5% | -10771.99% | -9528.46% | -12779.93% | -6260.46% | -143.67% | -17796.01% | -18624.56% | 21633.13% | -48.41% | - | -195.43% | 5.74% | -1991983.33% | -118335.11% | -95940.51% | -84600.56% | -738.2% |
| FCF Growth % | -6.36% | 24.02% | -102.02% | -85.08% | 20.93% | -18.39% | -149.67% | 48.06% | -155.23% | 29.61% | 1799.49% | 19% | 62.27% | 9.75% | 103.81% | -25.52% | 6.03% | -119.47% | -39.84% | -8.88% |
| FCF per Share | -0.93 | -0.90 | -1.14 | -1.03 | -0.93 | -1.31 | -0.63 | -0.59 | -1.26 | -1.13 | 1.33 | -1.19 | -0.53 | -1.73 | 0.07 | -1.53 | -1.43 | -1.96 | -1.95 | -1.24 |
| FCF Conversion (FCF/Net Income) | 0.80x | 0.92x | 0.89x | 0.71x | 0.80x | 0.55x | 0.40x | 1.34x | 1.24x | 0.76x | -0.94x | -1.08x | 0.36x | 1.71x | -0.17x | 1.02x | 0.60x | 0.76x | 0.75x | 0.61x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |